comparemela.com

Latest Breaking News On - West german study group - Page 1 : comparemela.com

Endocrine Therapy Response Status Is Necessary for Treatment Planning in HR+/HER2– Early Breast Cancer

Beyond genomic testing, endocrine therapy response should be used to determine whether patients with hormone receptor–positive, HER2-negative, N0-1 early breast cancer.

Consider Endocrine Therapy Responses When Planning Chemo in Breast Cancer Subset

Results from the ADAPTcycle trial found that endocrine therapy plus ovarian suppression can generate high response rates in patients with HR-positive, early breast cancer, regardless of age.

Exact Sciences (EXAS) Q2 2023 Earnings Call Transcript

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.